Knowledge Center

Many works are currently generated through use of artificial intelligence, which raises two important questions: Is it possible to protect these works through copyright and do these works expose the user to claims of copyright infringement? The answer to both these questions is “it depends,” and this is not an evasion, but rather analysis of the legal reality. Here are a number of tips that will assist you in protecting works and avoiding legal claims.

On March 27, 2024, the Israeli District Court in Jerusalem rendered a significant ruling in a Novartis case concerning Patent Term Extensions (PTEs), which has broad implications for pharmaceutical patent owners. The court accepted an appeal against a decision of the Registrar of Patents to revoke a PTE, which establishes the principle that PTEs in Israel are linked to the active ingredient and not to the first pharmaceutical preparation used to file the PTE application.

The past two years have brought many COVID-19-related challenges in almost every aspect, but as far as IP in Israel is concerned, it also created opportunities.